Brief: Kintor Pharmaceutical's Unit Enters Into Cooperation Agreement With Zhejiang Fonuw Medicine
12/03/2026 13:32
March 12 (Reuters) - Kintor Pharmaceutical Ltd 9939.HK: UNIT ENTERED INTO STRATEGIC COOPERATION AGREEMENT WITH ZHEJIANG FONUW MEDICINE DEAL TO COOPERATE ON RESEARCH AND DEVELOPMENT AND MANUFACTURING OF KT-939 COSMETICS Further company coverage: 9939.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kintor Pharmaceutical
See all newsBrief: Kintor Pharmaceutical Receives Invention Patent Grant For KT-939 In China
Brief: Kintor Pharmaceutical Says Ming Ming Cheung Resigns As CFO
Brief: Kintor Pharmaceutical Says CEO Via Wholly Owned Co Increases Shareholding By 2.51 Million Shares
Brief: Kintor Pharmaceutical Says YTD 2026 Sales Revenue At RMB34 Million
Brief: Kintor Pharmaceutical Says Pharma's Kx-826 Phase Iii Trial In China Reaches Primary Endpoint